Author

Chunfang Luan

Observed name: C. Luan

Institution: Sinovac Biotech

Observed institutions: Sinovac Biotech, Dalian Institute of Science and Technology

ORCID: 0000-0002-3234-2668

Observed ORCID: 0000-0002-3234-2668

OpenAlex ID: A5081568525

Efficacy, safety and immunogenicity of live attenuated varicella vaccine in healthy children in China: double-blind, randomized, placebo-controlled clinical trial

2019 · B. Hao, Z. Chen, et al. · Clinical Microbiology and Infection · 37

Immunogenicity and safety of a live-attenuated varicella vaccine in a healthy population aged 13 years and older: A randomized, double-blind, controlled study

2023 · Lili Huang, Zhen Chen, et al. · Vaccine · 8

Immunogenicity and safety of a live attenuated varicella vaccine co-administered with inactive hepatitis A vaccine: A phase 4, single-center, randomized, controlled trial

2023 · Dapeng Sun, Dan Yu, et al. · Human Vaccines & Immunotherapeutics · 8

Immunogenicity and Safety of Sabin Strain Inactivated Poliovirus Vaccine Booster Dose Administered Separately or Concomitantly with Inactivated Hepatitis A Vaccine or Measles–Mumps–Rubella Combined Attenuated Live Vaccine: An Open-Labelled, Randomized, Controlled, Phase 4 Clinical Trial

2025 · Jialei Hu, Weixiao Han, et al. · Vaccines · 4

Immunogenicity and Safety of a Live Attenuated Varicella Vaccine in Healthy Children Aged 12 to 15 Months: A Phase III, Randomized, Double-Blind, Active-Controlled Clinical Trial

2025 · Nancy Nazaire-Bermal, Ningning Jia, et al. · Vaccines · 4

Safety analysis of a live attenuated mumps vaccine in healthy adolescents in China: A phase 4, observational, open-label trial

2023 · Weijun Hu, Ningning Jia, et al. · PLoS ONE · 2

Works count: 6

Citation count: 63

H-index: 4

I10-index: 1